Cytokeratin-18 was a more sensitive marker of drug-induced liver disease than ALT, miR-122 or GLDH and has potential significant utility in the early identification of #DILI in trials and clinical practice. #OpenAccess https://t.co/19yI1f9Kcw
June 2024 @ToxSci#OpenAccess—Cytokeratin-18 Is a Sensitive Biomarker of Alanine Transaminase Increase in a Placebo-Controlled, Randomized, Crossover Trial of Therapeutic Paracetamol Dosing (PATH-BP Biomarker Substudy) https://t.co/xtXthJPDTb
Delighted to receive the Medical Device and Combination Product Specialty Section Achievement Award this week at my first @SOToxicology meeting. #2024SOT
Congratulations to Dr @KMScullion and Dr Fiona Chapman - winners of our ECR Showcase!
Pictured together with the chairs Dr @natkjones and Dr Ineke Luijten
#CVS2022
Delighted to have my PhD work published that I carried out at @EdinUniCVS with @EdinClinTox. Thank you to everyone involved!
Circulating argonaute-bound microRNA-126 reports vascular dysfunction & treatment response in acute & chronic kidney disease.